{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:42:25Z","timestamp":1789494145403,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903414"],"award-info":[{"award-number":["81903414"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Despite the importance of medication adherence in treatment effectiveness, little is known about the association between medication non-adherence and self-inflicted violence behaviors. We aimed to assess whether medication non-adherence increased the risk of self-inflicted violence behaviors among schizophrenics in communities (hypothesis 1) and whether the dose\u2013response relationship existed (hypothesis 2).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This 12-year cohort study in western China recruited 292,667 community-dwelling schizophrenics. The proportion of regular medication (PRM) was calculated by dividing the time of \u201cregular adherence\u201d by the total time of antipsychotic treatment during follow-up period as an indicator of medication adherence. For hypothesis 1, medication adherence was designated as a binary variable with a threshold of 0.8 (PRM); for hypothesis 2, medication adherence was specified as five-category and continuous variables, respectively. Inverse probability weighting and mixed effects Cox proportional hazards models were conducted for confounders control and survival analyses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>One hundred eighty-five thousand eight hundred participants were eligible for the final analyses, with a mean age of 47.49\u00a0years (SD 14.55\u00a0years), of whom 53.6% were female. For hypothesis 1, the medication non-adherence group (PRM\u2009&lt;\u20090.8) had a lower risk of suicide (HR, 0.527, 95% CI, 0.447\u20130.620), an increased risk of NSSI (HR, 1.229, 95% CI, 1.088\u20131.388), and non-significant risk of attempted suicide compared with adherence group (PRM\u2009\u2265\u20090.8). For hypothesis 2, the lowest medication adherence (PRM\u2009&lt;\u20090.2) was associated with increased risks of suicide attempt (HR, 1.614, 95% CI, 1.412\u20131.845), NSSI (HR, 1.873, 95% CI, 1.649\u20132.126), and a decreased risk of suicide (HR, 0.593, 95% CI, 0.490\u20130.719). The other non-adherence groups had lower risks for all three self-inflicted violence behaviors. The associations between medication adherence in continuous-variable and three outcomes were consistent with the categorical medication adherence results.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Almost no medication taken as prescribed was associated with an increased risk of suicide attempt and NSSI. However, medication adherence did not appear to prevent completed suicide. Besides, patients with moderate adherence had a lower incidence of suicide attempt and NSSI. These findings highlight the need for a more detailed portrayal of medication adherence and the need to be vigilant for suicide intent in schizophrenics with good medication adherence who may be overlooked previously.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-024-03354-7","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T03:43:41Z","timestamp":1711338221000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Medication non-adherence and self-inflicted violence behaviors among 185,800 patients with schizophrenia in the community: a 12-year cohort study"],"prefix":"10.1186","volume":"22","author":[{"given":"Chuanlong","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianmei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangrui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1683-5809","authenticated-orcid":false,"given":"Yuanyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,25]]},"reference":[{"issue":"2","key":"3354_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1001\/jamapsychiatry.2019.3360","volume":"77","author":"RA McCutcheon","year":"2020","unstructured":"McCutcheon RA, Reis Marques T, Howes OD. Schizophrenia-an overview. JAMA Psychiat. 2020;77(2):201\u201310.","journal-title":"JAMA Psychiat"},{"issue":"2","key":"3354_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"Collaborators GBDMD","year":"2022","unstructured":"Collaborators GBDMD. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9(2):137\u201350.","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"3354_CR3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S2215-0366(17)30078-0","volume":"4","author":"C Hjorth\u00f8j","year":"2017","unstructured":"Hjorth\u00f8j C, St\u00fcrup AE, McGrath JJ, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry. 2017;4(4):295\u2013301.","journal-title":"Lancet Psychiatry"},{"issue":"12","key":"3354_CR4","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1001\/jamapsychiatry.2015.1737","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiat. 2015;72(12):1172\u201381.","journal-title":"JAMA Psychiat"},{"issue":"8","key":"3354_CR5","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1001\/jamapsychiatry.2021.0841","volume":"78","author":"M Olfson","year":"2021","unstructured":"Olfson M, Stroup TS, Huang C, Wall MM, Crystal S, Gerhard T. Suicide risk in medicare patients with schizophrenia across the life span. JAMA Psychiat. 2021;78(8):876\u201385.","journal-title":"JAMA Psychiat"},{"key":"3354_CR6","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1017\/S2045796019000313","volume":"29","author":"L Lu","year":"2019","unstructured":"Lu L, Dong M, Zhang L, et al. Prevalence of suicide attempts in individuals with schizophrenia: a meta-analysis of observational studies. Epidemiol Psychiatr Sci. 2019;29:e39.","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"2","key":"3354_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1192\/bjp.bp.107.040113","volume":"192","author":"MK Nock","year":"2008","unstructured":"Nock MK, Borges G, Bromet EJ, et al. Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br JPsychiatry. 2008;192(2):98\u2013105.","journal-title":"Br JPsychiatry"},{"key":"3354_CR8","doi-asserted-by":"publisher","first-page":"102068","DOI":"10.1016\/j.ajp.2020.102068","volume":"52","author":"E G\u00fcney","year":"2020","unstructured":"G\u00fcney E, Aln\u0131ak \u0130, Erk\u0131ran M. Predicting factors for non-suicidal self-injury in patients with schizophrenia spectrum disorders and the role of substance use. Asian J Psychiatr. 2020;52:102068.","journal-title":"Asian J Psychiatr"},{"issue":"5","key":"3354_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1177\/0141076814522033","volume":"107","author":"A Singhal","year":"2014","unstructured":"Singhal A, Ross J, Seminog O, Hawton K, Goldacre MJ. Risk of self-harm and suicide in people with specific psychiatric and physical disorders: comparisons between disorders using English national record linkage. J R Soc Med. 2014;107(5):194\u2013204.","journal-title":"J R Soc Med"},{"issue":"8","key":"3354_CR10","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1176\/appi.ajp.2017.16111288","volume":"174","author":"M Olfson","year":"2017","unstructured":"Olfson M, Wall M, Wang S, Crystal S, Gerhard T, Blanco C. Suicide following deliberate self-harm. Am J Psychiatry. 2017;174(8):765\u201374.","journal-title":"Am J Psychiatry"},{"issue":"10039","key":"3354_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","volume":"388","author":"MJ Owen","year":"2016","unstructured":"Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet. 2016;388(10039):86\u201397.","journal-title":"Lancet"},{"issue":"4","key":"3354_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/acps.12857","volume":"137","author":"CH Ma","year":"2018","unstructured":"Ma CH, Chang SS, Tsai HJ, et al. Comparative effect of antipsychotics on risk of self-harm among patients with schizophrenia. Acta Psychiatr Scand. 2018;137(4):296\u2013305.","journal-title":"Acta Psychiatr Scand"},{"issue":"7","key":"3354_CR13","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/jamapsychiatry.2017.1322","volume":"74","author":"J Tiihonen","year":"2017","unstructured":"Tiihonen J, Mittendorfer-Rutz E, Majak M, et al. Real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29 823 patients with schizophrenia. JAMA Psychiat. 2017;74(7):686\u201393.","journal-title":"JAMA Psychiat"},{"issue":"2","key":"3354_CR14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/wps.20994","volume":"21","author":"CU Correll","year":"2022","unstructured":"Correll CU, Solmi M, Croatto G, et al. Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors. World Psychiatry. 2022;21(2):248\u201371.","journal-title":"World Psychiatry"},{"issue":"2\u20133","key":"3354_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.psychres.2009.05.004","volume":"176","author":"D Novick","year":"2010","unstructured":"Novick D, Haro JM, Suarez D, Perez V, Dittmann RW, Haddad PM. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Res. 2010;176(2\u20133):109\u201313.","journal-title":"Psychiatry Res"},{"issue":"3","key":"3354_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.psychres.2008.03.018","volume":"167","author":"M Pompili","year":"2009","unstructured":"Pompili M, Lester D, Grispini A, et al. Completed suicide in schizophrenia: evidence from a case-control study. Psychiatry Res. 2009;167(3):251\u20137.","journal-title":"Psychiatry Res"},{"issue":"4","key":"3354_CR17","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/schbul\/sbx131","volume":"44","author":"RM Cassidy","year":"2018","unstructured":"Cassidy RM, Yang F, Kapczinski F, Passos IC. Risk factors for suicidality in patients with schizophrenia: a systematic review, meta-analysis, and meta-regression of 96 studies. Schizophr Bull. 2018;44(4):787\u201397.","journal-title":"Schizophr Bull"},{"issue":"4","key":"3354_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/00207411.1996.11449377","volume":"25","author":"J Peuskens","year":"2015","unstructured":"Peuskens J, De Hert M, Cosyns P, Pieters G, Theys P, Vermote R. Suicide in young schizophrenic patients during and after inpatient treatment. Int J Ment Health. 2015;25(4):39\u201344.","journal-title":"Int J Ment Health"},{"issue":"2\u20133","key":"3354_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0920-9964(00)00003-7","volume":"47","author":"M De Hert","year":"2001","unstructured":"De Hert M, McKenzie K, Peuskens J. Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study. Schizophr Res. 2001;47(2\u20133):127\u201334.","journal-title":"Schizophr Res"},{"issue":"4","key":"3354_CR20","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/oxfordjournals.schbul.a007133","volume":"30","author":"JM Sinclair","year":"2004","unstructured":"Sinclair JM, Mullee MA, King EA, Baldwin DS. Suicide in schizophrenia: a retrospective case-control study of 51 suicides. Schizophr Bull. 2004;30(4):803\u201311.","journal-title":"Schizophr Bull"},{"issue":"6","key":"3354_CR21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s00127-008-0460-8","volume":"44","author":"S Hodgins","year":"2008","unstructured":"Hodgins S, Lincoln T, Mak T. Experiences of victimisation and depression are associated with community functioning among men with schizophrenia. Soc Psychiatry Psychiatr Epidemiol. 2008;44(6):448\u201357.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"11","key":"3354_CR22","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/j.clinthera.2006.11.002","volume":"28","author":"A Ward","year":"2006","unstructured":"Ward A, Ishak K, Proskorovsky I, Caro J. Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database study. Clin Ther. 2006;28(11):1912\u201321.","journal-title":"Clin Ther"},{"issue":"3","key":"3354_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/wps.20060","volume":"12","author":"JM Kane","year":"2013","unstructured":"Kane JM, Kishimoto T, Correll CU. Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies. World Psychiatry. 2013;12(3):216\u201326.","journal-title":"World Psychiatry"},{"issue":"4","key":"3354_CR24","doi-asserted-by":"publisher","first-page":"e235891","DOI":"10.1001\/jamanetworkopen.2023.5891","volume":"6","author":"Y Li","year":"2023","unstructured":"Li Y, Wen H, Xiong C, et al. Medication nonadherence and risk of violence to others among patients with schizophrenia in Western China. JAMA Netw Open. 2023;6(4):e235891.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"3354_CR25","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/pds.1230","volume":"15","author":"SE Andrade","year":"2006","unstructured":"Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15(8):565\u201374.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3354_CR26","doi-asserted-by":"publisher","first-page":"217047","DOI":"10.1155\/2015\/217047","volume":"2015","author":"WY Lam","year":"2015","unstructured":"Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015:217047.","journal-title":"Biomed Res Int"},{"issue":"5","key":"3354_CR27","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","volume":"11","author":"JM Robins","year":"2000","unstructured":"Robins JM, Hern\u00e1n M\u00c1, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11(5):550\u201360.","journal-title":"Epidemiology"},{"issue":"14","key":"3354_CR28","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1001\/jama.2020.1267","volume":"323","author":"MJ Stensrud","year":"2020","unstructured":"Stensrud MJ, Hern\u00e1n MA. Why test for proportional hazards? JAMA. 2020;323(14):1401\u20132.","journal-title":"JAMA"},{"issue":"19","key":"3354_CR29","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/sim.4274","volume":"30","author":"P Royston","year":"2011","unstructured":"Royston P, Parmar MKB. The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt. Stat Med. 2011;30(19):2409\u201321.","journal-title":"Stat Med"},{"issue":"4","key":"3354_CR30","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Internal Med. 2017;167(4):268\u201374.","journal-title":"Ann Internal Med."},{"issue":"2","key":"3354_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/schbul\/sby092","volume":"45","author":"M Belvederi Murri","year":"2019","unstructured":"Belvederi Murri M, Amore M. The multiple dimensions of insight in schizophrenia-spectrum disorders. Schizophr Bull. 2019;45(2):277\u201383.","journal-title":"Schizophr Bull"},{"issue":"4 Suppl","key":"3354_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/1359786810385490","volume":"24","author":"K Hor","year":"2010","unstructured":"Hor K, Taylor M. Suicide and schizophrenia: a systematic review of rates and risk factors. J Psychopharmacol (Oxford, England). 2010;24(4 Suppl):81\u201390.","journal-title":"J Psychopharmacol (Oxford, England)"},{"key":"3354_CR33","doi-asserted-by":"publisher","first-page":"848472","DOI":"10.3389\/fphar.2022.848472","volume":"13","author":"K Guo","year":"2022","unstructured":"Guo K, Feng Z, Chen S, Yan Z, Jiao Z, Feng D. Safety profile of antipsychotic drugs: analysis based on a provincial spontaneous reporting systems database. Front Pharmacol. 2022;13:848472.","journal-title":"Front Pharmacol"},{"issue":"2","key":"3354_CR34","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nrendo.2011.156","volume":"8","author":"M De Hert","year":"2011","unstructured":"De Hert M, Detraux J, van Winkel R, Yu W, Correll CU. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol. 2011;8(2):114\u201326.","journal-title":"Nat Rev Endocrinol"},{"key":"3354_CR35","doi-asserted-by":"crossref","unstructured":"Ceraso A, Lin JJ, Schneider-Thoma J, Siafis S, Tardy M, Komossa K, et al. Maintenance treatment with antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev. 2020;8(8):Cd008016.","DOI":"10.1002\/14651858.CD008016.pub3"},{"key":"3354_CR36","doi-asserted-by":"publisher","first-page":"c3222","DOI":"10.1136\/bmj.c3222","volume":"341","author":"B Runeson","year":"2010","unstructured":"Runeson B, Tidemalm D, Dahlin M, Lichtenstein P, L\u00e5ngstr\u00f6m N. Method of attempted suicide as predictor of subsequent successful suicide: national long term cohort study. BMJ (Clinical research ed). 2010;341:c3222.","journal-title":"BMJ (Clinical research ed)"},{"issue":"sup1","key":"3354_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13811118.2018.1563575","volume":"24","author":"A Brereton","year":"2020","unstructured":"Brereton A, McGlinchey E. Self-harm, emotion regulation, and experiential avoidance: a systematic review. Arch Suicide Res. 2020;24(sup1):1\u201324.","journal-title":"Arch Suicide Res"},{"issue":"10","key":"3354_CR38","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S2215-0366(22)00303-0","volume":"9","author":"W Zhou","year":"2022","unstructured":"Zhou W, Xiao S. Low use of the management and treatment services for psychosis in China. Lancet Psychiatry. 2022;9(10):763\u20134.","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"3354_CR39","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/YCO.0000000000000506","volume":"32","author":"GK Ryan","year":"2019","unstructured":"Ryan GK, Semrau M, Nkurunungi E, Mpango RS. Service user involvement in global mental health: what have we learned from recent research in low and middle-income countries? Curr Opin Psychiatry. 2019;32(4):355\u201360.","journal-title":"Curr Opin Psychiatry"},{"issue":"6","key":"3354_CR40","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1192\/bjo.2020.106","volume":"6","author":"MS Ran","year":"2020","unstructured":"Ran MS, Xiao Y, Fazel S, Lee Y, Luo W, Hu SH, et al. Mortality and suicide in schizophrenia: 21-year follow-up in rural China. BJPsych Open. 2020;6(6):e121.","journal-title":"BJPsych Open"},{"issue":"8","key":"3354_CR41","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00127-020-01985-8","volume":"56","author":"CH Pan","year":"2021","unstructured":"Pan CH, Chen PH, Chang HM, Wang IS, Chen YL, Su SS, et al. Incidence and method of suicide mortality in patients with schizophrenia: a Nationwide Cohort Study. Soc Psychiatry Psychiatr Epidemiol. 2021;56(8):1437\u201346.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"3354_CR42","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1017\/S2045796019000313","volume":"29","author":"L Lu","year":"2019","unstructured":"Lu L, Dong M, Zhang L, Zhu XM, Ungvari GS, Ng CH, et al. Prevalence of suicide attempts in individuals with schizophrenia: a meta-analysis of observational studies. Epidemiol Psychiatr Sci. 2019;29:e39.","journal-title":"Epidemiol Psychiatr Sci"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-024-03354-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-024-03354-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-024-03354-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T05:11:21Z","timestamp":1711343481000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-024-03354-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,25]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3354"],"URL":"https:\/\/doi.org\/10.1186\/s12916-024-03354-7","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,25]]},"assertion":[{"value":"28 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee of Sichuan University. All patients provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"136"}}